Showing results (191-200 of 308) with videos related to
Sort By:
Pageof 31
Magnesium Research|October 1, 1996
Changes in the haemostatic profile during magnesium deficiency in swineV L Serebruany, W R Herzog, L R Edenbaum, et al.Cardiology|August 7, 1998
Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction. The GUSTO-III Platelet SubstudyV L Serebruany, R D Bahr, C M O'Connor, et al.Journal of Thrombosis and Thrombolysis|June 15, 2001
Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency departmentV L Serebruany, D J Levine, G V Nair, et al.American Heart Journal|March 28, 2003
Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?Alex I Malinin, Christopher M O'Connor, Alec I Dzhanashvili, et al.Pharmacology|October 1, 1996
Intracoronary magnesium and diltiazem affect to a similar extent certain hemostatic factors during acute myocardial infarction in swineV L Serebruany, M L Schlossberg, L R Edenbaum, et al.Journal of Cardiovascular Pharmacology|December 1, 1996
Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swineV L Serebruany, W R Herzog, M L Schlossberg, et al.International Journal of Cardiology|August 29, 1997
Effects of intracoronary diltiazem on certain hemostatic parameters during acute myocardial infarction in swineV L Serebruany, M L Schlossberg, L R Edenbaum, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Impact of renal impairment on platelet reactivity and clinical outcomes during chronic dual antiplatelet therapy following coronary stentingLong Zhe Guo, Moo Hyun Kim, Chang Heon Shim, et al.Pharmacological Research|October 23, 1998
Serial changes of soluble endothelin-1 levels during myocardial ischaemia-reperfusion. Effects of magnesium, diltiazem and a novel MAC-1 inhibitorV L Serebruany, M L Schlossberg, L R Edenbaum, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 9, 2007
Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity?Alex I Malinin, Benjamin R Oshrine, David C Sane, et al.Pageof 31